Kristin Stephens - Net Worth and Insider Trading
Kristin Stephens Net Worth
The estimated net worth of Kristin Stephens is at least $0 dollars as of 2025-07-04. Kristin Stephens is the Chief Development Officer of Syros Pharmaceuticals Inc and owns about 0 shares of Syros Pharmaceuticals Inc (SYRS) stock worth over $0. Details can be seen in Kristin Stephens's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kristin Stephens has not made any transactions after 2024-11-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kristin Stephens
Kristin Stephens Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kristin Stephens owns 1 companies in total, including Syros Pharmaceuticals Inc (SYRS) .
Click here to see the complete history of Kristin Stephens’s form 4 insider trades.
Insider Ownership Summary of Kristin Stephens
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| SYRS | Syros Pharmaceuticals Inc | 2024-11-18 | Chief Development Officer |
Kristin Stephens Latest Holdings Summary
Kristin Stephens currently owns a total of 1 stock. Kristin Stephens owns 0 shares of Syros Pharmaceuticals Inc (SYRS) as of November 18, 2024, with a value of $0.
Latest Holdings of Kristin Stephens
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SYRS | Syros Pharmaceuticals Inc | 2024-11-18 | 0 | 0.03 | 0 |
Holding Weightings of Kristin Stephens
Kristin Stephens Form 4 Trading Tracker
According to the SEC Form 4 filings, Kristin Stephens has made a total of 1 transactions in Syros Pharmaceuticals Inc (SYRS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Syros Pharmaceuticals Inc is the sale of 36,133 shares on November 18, 2024, which brought Kristin Stephens around $7,949.
Insider Trading History of Kristin Stephens
- 1
Kristin Stephens Trading Performance
Kristin Stephens Ownership Network
Ownership Network List of Kristin Stephens
Ownership Network Relation of Kristin Stephens
Kristin Stephens Owned Company Details
What does Syros Pharmaceuticals Inc do?
Who are the key executives at Syros Pharmaceuticals Inc?
Kristin Stephens is the Chief Development Officer of Syros Pharmaceuticals Inc. Other key executives at Syros Pharmaceuticals Inc include director & 10 percent owner & President & CEO Nancy A Simonian , Chief Legal Officer Gerald E Quirk , and Chief Medical Officer David Roth .
Syros Pharmaceuticals Inc (SYRS) Insider Trades Summary
Over the past 18 months, Kristin Stephens made 1 insider transaction in Syros Pharmaceuticals Inc (SYRS) with a net sale of 36,133. Other recent insider transactions involving Syros Pharmaceuticals Inc (SYRS) include a net sale of 22,700 shares made by David Roth , a net sale of 171,783 shares made by Nancy A Simonian , and a net sale of 37,803 shares made by Jason Haas .
In summary, during the past 3 months, insiders sold 0 shares of Syros Pharmaceuticals Inc (SYRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 549,873 shares of Syros Pharmaceuticals Inc (SYRS) were sold and 200,000 shares were bought by its insiders, resulting in a net sale of 349,873 shares.
Syros Pharmaceuticals Inc (SYRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Syros Pharmaceuticals Inc Insider Transactions
Kristin Stephens Mailing Address
Above is the net worth, insider trading, and ownership report for Kristin Stephens. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Kristin Stephens's mailing address is: Cambridge Ma 02140.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
